vaccines | pharmaphorum

Wednesday 2 April 2025

Channels

Content type

Categories

Categories

Sort by

Order

vaccines

News

Jean-François Toussaint, Sanofi's global head of vaccines R&D

FDA fast-tracks Sanofi's experimental chlamydia vaccine

Sanofi is preparing to start human testing of its chlamydia vaccine, now fast-tracked by the FDA, that it hopes will be the first to reach the market.

Market Access

JP Morgan Week 2025 – Jeff Fischer

JP Morgan Week 2025 – Jeff Fischer

News

FDA chooses flu vaccine strains despite cancelled meeting

FDA chooses flu vaccine strains despite cancelled meeting

The FDA has released its recommendations on the composition of influenza vaccines for the 2025-26 season – without the input of its external advisors.

News

A pile of syringes

Vaccine sector on edge as HHS cancels flu meeting

An FDA advisory committee due to be held in March to discuss the formulation of influenza vaccines for the 2025/26 flu season has been cancelled.

R&D

Ryan Spencer at JP Morgan week 25 interview with Jonah Comstock

JP Morgan Week 2025 – Ryan Spencer

Join CEO Ryan Spencer of Dynavax Technologies in a video interview discussing JP Morgan Week 2025

News

CDC HQ

Kennedy delays first vaccine expert meeting under his watch

Less than a week into the tenure of Robert F Kennedy Jr as HHS secretary, there are more signals that US immunisation is going to be shaken up.